Reduced Antibody Acquisition with Increasing Age following Vaccination with BNT162b2: Results from Two Longitudinal Cohort Studies in The Netherlands

Vaccine-induced protection against severe COVID-19, hospitalization, and death is of the utmost importance, especially in the elderly. However, limited data are available on humoral immune responses following COVID-19 vaccination in the general population across a broad age range. We performed an integrated analysis of the effect of age, sex, and prior SARS-CoV-2 infection on Spike S1-specific (S1) IgG concentrations up to three months post-BNT162b2 (Pfizer/BioNTech; Comirnaty) vaccination. In total, 1735 persons, eligible for COVID-19 vaccination through the national program, were recruited f... Mehr ...

Verfasser: Lotus Leonie van den Hoogen
Mardi Boer
Abigail Postema
Lia de Rond
Mary-lène de Zeeuw-Brouwer
Inge Pronk
Alienke Jentien Wijmenga-Monsuur
Elske Bijvank
Caitlyn Kruiper
Lisa Beckers
Marjan Bogaard-van Maurik
Ilse Zutt
Jeffrey van Vliet
Rianne van Bergen
Marjan Kuijer
Gaby Smits
W. M. Monique Verschuren
H. Susan J. Picavet
Fiona Regina Maria van der Klis
Gerco den Hartog
Robert Samuel van Binnendijk
Anne-Marie Buisman
Dokumenttyp: Artikel
Erscheinungsdatum: 2022
Reihe/Periodikum: Vaccines, Vol 10, Iss 1480, p 1480 (2022)
Verlag/Hrsg.: MDPI AG
Schlagwörter: COVID-19 / BNT162b2 / antibody / Medicine / R
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-29170638
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://doi.org/10.3390/vaccines10091480